Thank you for visiting the patient information page 

​

Your doctor has recommended Pegasys® (peginterferon alfa-2a) as a suitable treatment option for you. As a 
patient currently being prescribed Pegasys® we wanted to update you on some important changes that will 
impact how you receive your treatment moving forward.

From 1 September 2024, Australian patients prescribed Pegasys® will only be able to access this treatment through the new dedicated Pegasys®   Home Delivery Program. This program is delivered by Echo Therapeutics (the sponsor of Pegasys® in Australia) through its EchoCare™ service, in partnership with JustMeds – a local 
specialist medicines delivery provider. This is initially a short- to medium-term solution to make sure Australian patients prescribed Pegasys® can continue to access treatment when needed. 

​

​Please find below information and the steps to how to arrange delivery of Pegasys® (peginterferon alfa-2a) from   

1 September 2024.

​​

​​​​​​​​​​​​​​​​If you would like to speak to someone from the JustMeds team, please click here to email the team or phone  

07 2000 4124.​